Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (Q53022653)
Jump to navigation
Jump to search
scientific article published on 5 September 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. |
scientific article published on 5 September 2014 |
Statements
Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy (English)
Fernanda Genre
Raquel López-Mejías
José A Miranda-Filloy
Begoña Ubilla
Beatriz Carnero-López
Natalia Palmou-Fontana
Inés Gómez-Acebo
Javier Rueda-Gotor
Trinitario Pina
Carlos González-Juanatey
Javier Llorca
Miguel Á González-Gay
5 September 2014